Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|July 17, 1997
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagusJ F Bosset, M Gignoux, J P Triboulet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.
The British Journal of Surgery|August 13, 2009
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgeryM den Dulk, C A M Marijnen, L Collette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1994
The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinomaJ G Letschert, J V Lebesque, B M Aleman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative GroupsJ F Bosset, F Roelofsen, D A L Morgan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinomaS Kim, M Jary, L Mansi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 31, 2016
Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practiceC Bednarek, T V F Nguyen, M Puyraveau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO studyB Chauffert, F Mornex, F Bonnetain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaM Ducreux, P Rougier, J-P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)O Matzinger, F Roelofsen, L Mineur, et al.
Pageof 9